Locations:
Search
TRAF4 may be a viable therapeutic target
71% of papers with comparative stats have at least one error
S6K1 pathway could be a promising therapeutic target
Understanding resistance in PARP inhibitor therapy
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Dr. Jianjun Zhao receives two-year grant
PON2 associated with high-density lipoprotein
Research takes us a step closer
New center dedicated to studying their role
Inhibiting gene expression boosts treatment
Internal award provides funding to cross-disciplinary project
Advertisement
Advertisement